Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.93
+0.09 (1.32%)
At close: Feb 27, 2026, 4:00 PM EST
6.85
-0.08 (-1.15%)
After-hours: Feb 27, 2026, 7:27 PM EST
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $148.94 million as of February 27, 2026. Its market cap has increased by 169.92% in one year.
Market Cap
148.94M
Enterprise Value
106.51M
1-Year Change
169.92%
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $148.94M, an increase of 124.00%. That is a compound annual growth rate of 19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 148.94M | 20.10% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 163.54M |
| Zentalis Pharmaceuticals | 159.93M |
| Whitehawk Therapeutics | 153.17M |
| Corbus Pharmaceuticals Holdings | 152.86M |
| Polaryx Therapeutics | 151.03M |
| Adagene | 146.34M |
| Black Diamond Therapeutics | 142.44M |
| Connect Biopharma Holdings | 141.99M |